Value: Changes in the Detection and Recognition Thresholds of Three Basic Tastes in Lung Cancer Patients Receiving Cisplatin and Paclitaxel and Its Association with Nutritional and Quality of Life Parameters

References

• Arrieta O, Guzman-de Alba E, Alba-Lopez LF, Acosta-Espinoza A, Alatorre-Alexander J, et al.: [National consensus of diagnosis and treatment of non-small cell lung cancer]. Rev Invest Clin 65, S5–S84, 2013.
   PubMedGoogle Scholar
• Sanchez-Lara K, Turcott JG, Juarez E, Guevara P, Nunez-Valencia C, et al.: Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer 64, 526–534, 2012.
   PubMed Web of Science ®Google Scholar
• Arrieta O, De la Torre M, Pérez D, Turcott JG, Juárez E, Sanchez-Lara K, and López D: Association of clinical and nutritional factors with treatment related toxicity of “fixed standard dose” of afatinib in patients with advanced NSCLC. J Clin Oncol 31, ( suppl; abstr e19068), 2013.
   Google Scholar
• Arrieta O, Michel Ortega RM, Villanueva-Rodriguez G, Serna-Thome MG, Flores-Estrada D, et al.: Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 10, 50, 2010.
   PubMed Web of Science ®Google Scholar
• de Cos Escuin JS, Delgado IU, Rodriguez JC, Lopez MJ, Vicente CD, et al.: [Stage IIIA and IIIB non-small cell lung cancer: results of chemotherapy combined with radiation therapy and analysis of prognostic factors]. Arch Bronconeumol 43, 358–365, 2007.
   PubMed Web of Science ®Google Scholar
• Sanchez-Lara K, Turcott JG, Juarez-Hernandez E, Nunez-Valencia C, Villanueva G, et al.: Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: Randomised trial. Clin Nutr 33, 1017–1023, 2014.
   PubMed Web of Science ®Google Scholar
• Sanchez-Lara K, Arrieta O, Pasaye E, Laviano A, Mercadillo RE, et al.: Brain activity correlated with food preferences: a functional study comparing advanced non-small cell lung cancer patients with and without anorexia. Nutrition 29, 1013–1019, 2013.
   PubMed Web of Science ®Google Scholar
• Sanchez-Lara K, Sosa-Sanchez R, Green-Renner D, Rodriguez C, Laviano A, et al.: Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy. Nutr J 9, 15, 2010.
   PubMed Web of Science ®Google Scholar
• Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, et al.: A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18, 1081–1017, 2010.
   PubMed Web of Science ®Google Scholar
• Belqaid K, Orrevall Y, McGreevy J, Mansson-Brahme E, Wismer W, et al.: Self-reported taste and smell alterations in patients under investigation for lung cancer. Acta Oncol 53, 1405–1412, 2014.
   PubMed Web of Science ®Google Scholar
• Stinchcombe TE: Novel agents in development for advanced non-small cell lung cancer. Ther Adv Med Oncol 6, 240–253, 2014.
   PubMed Web of Science ®Google Scholar
• Macedo-Perez EO, Morales-Oyarvide V, Mendoza-Garcia VO, Dorantes-Gallareta Y, Flores-Estrada D, et al.: Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 74, 681–690, 2014.
   PubMed Web of Science ®Google Scholar
• Comeau TB, Epstein JB, and Migas C: Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer 9, 575–580, 2001.
   PubMed Web of Science ®Google Scholar
• Arrieta O, Hernandez-Pedro N, Fernandez-Gonzalez-Aragon MC, Saavedra-Perez D, Campos-Parra AD, et al.: Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer. Neurology 77, 987–995, 2011.
   PubMed Web of Science ®Google Scholar
• Bernhardson BM, Tishelman C, and Rutqvist LE: Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer 16, 275–283, 2008.
   PubMed Web of Science ®Google Scholar
• Hutton JL, Baracos VE, and Wismer WV: Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manage 33, 156–165, 2007.
   PubMed Web of Science ®Google Scholar
• Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, et al.: Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr 29, 154–159, 2010.
   PubMed Web of Science ®Google Scholar
• Hernandez-Avila M, Romieu I, Parra S, Hernandez-Avila J, Madrigal H, et al.: Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 40, 133–140, 1998.
   PubMed Web of Science ®Google Scholar
• Arrieta O, Nunez-Valencia C, Reynoso-Erazo L, Alvarado S, Flores-Estrada D, et al.: Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire. Lung Cancer 77, 205–211, 2012.
   PubMed Web of Science ®Google Scholar
• Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, and Sullivan M: The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 30A, 635–642, 1994.
   PubMed Web of Science ®Google Scholar
• McGreevy J, Orrevall Y, Belqaid K, Wismer W, Tishelman C, et al.: Characteristics of taste and smell alterations reported by patients after starting treatment for lung cancer. Support Care Cancer 22, 2635–2644, 2014.
   PubMed Web of Science ®Google Scholar
• Hoffman HJ, Cruickshanks KJ, and Davis B: Perspectives on population-based epidemiological studies of olfactory and taste impairment. Ann N Y Acad Sci 1170, 514–530, 2009.
   PubMed Web of Science ®Google Scholar
• Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, et al.: Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15, 39–46, 2007.
   PubMed Web of Science ®Google Scholar
• Brisbois TD, de Kock IH, Watanabe SM, Baracos VE, and Wismer WV: Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life. J Pain Symptom Manage 41, 673–83, 2011.
   PubMed Web of Science ®Google Scholar
• Hong JH, Omur-Ozbek P, Stanek BT, Dietrich AM, Duncan SE, et al.: Taste and odor abnormalities in cancer patients. J Support Oncol 7, 58–65, 2009.
   PubMedGoogle Scholar
• Duffy V, Fast K, Lucchina L, and Bartoshuk L. Oral sensation and cancer. In: Principles and practice of palliative care and supportive oncology, 2nd ed., Berger A, Portenoy R, Weissman D (eds.). Philadelphia: Lippincott Williams & Wilkins, 2002, pp. 178–193.
   Google Scholar
• Steinbach S, Hummel T, Bohner C, Berktold S, Hundt W, et al.: Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol 27, 1899–1905, 2009.
   PubMed Web of Science ®Google Scholar
• Nishijima S, Yanase T, Tsuneki I, Tamura M, and Kurabayashi T: Examination of the taste disorder associated with gynecological cancer chemotherapy. Gynecol Oncol 131, 674–8, 2013.
   PubMed Web of Science ®Google Scholar
• Mouritsen OG: Umami flavour as a means of regulating food intake and improving nutrition and health. Nutr Health 21, 56–75, 2012.
   PubMedGoogle Scholar
• Ovesen L, Hannibal J, and Sorensen M: Taste thresholds in patients with small-cell lung cancer. J Cancer Res Clin Oncol 117, 70–72, 1991.
   PubMed Web of Science ®Google Scholar
• Mattes RD, Cowart BJ, Schiavo MA, Arnold C, Garrison B, et al.: Dietary evaluation of patients with smell and/or taste disorders. Am J Clin Nutr 51, 233–240, 1990.
   PubMed Web of Science ®Google Scholar
• Coa KI, Epstein JB, Ettinger D, Jatoi A, McManus K, et al.: The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment. Nutr Cancer 67, 339–353, 2015.
   PubMed Web of Science ®Google Scholar
• Henkin RI: Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf 11, 318–377, 1994.
   PubMed Web of Science ®Google Scholar
• King JC: Assessment of zinc status. J Nutr 120, 1474–1479, 1990.
   PubMed Web of Science ®Google Scholar
• Bales CW, Steinman LC, Freeland-Graves JH, Stone JM, and Young RK: The effect of age on plasma zinc uptake and taste acuity. Am J Clin Nutr 44, 664–669, 1986.
   PubMed Web of Science ®Google Scholar
• Krarup B: Electro-gustometry: a method for clinical taste examinations. Acta Otolaryngol 49, 294–305, 1958.
   PubMedGoogle Scholar
• Berling K, Knutsson J, Rosenblad A, and von Unge M: Evaluation of electrogustometry and the filter paper disc method for taste assessment. Acta Otolaryngol 131, 488–493, 2011.
   PubMed Web of Science ®Google Scholar
• Imai H, Soeda H, Komine K, Otsuka K, and Shibata H: Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer. BMC Palliat Care 12, 38, 2013.
   PubMed Web of Science ®Google Scholar
• Kano T and Kanda K: Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum 40, E79–E85, 2013.
   PubMedGoogle Scholar